|
4,4'-Methylenebis(2-chloroaniline) |
CAS 101-14-4 | ||
CH2(C6H4ClNH2)2 |
RTECS CY1050000 | ||
Synonyms & Trade Names DACPM; 3,3'-Dichloro-4,4'-diaminodiphenylmethane; MBOCA; 4,4'-Methylenebis(o-chloro aniline); 4,4'-Methylenebis(2-chlorobenzenamine); MOCA |
DOT ID & Guide |
Exposure
|
NIOSH REL: Ca TWA 0.003 mg/m3 [skin] See Appendix A | ||
OSHA PEL†: none | |||
IDLH Ca [N.D.] See: IDLH INDEX | Conversion |
Physical Description Tan-colored pellets or flakes with a faint, amine-like odor. |
|||
MW: 267.2 |
BP: ? |
MLT: 230°F |
Sol: Slight |
VP(77°F): 0.00001 mmHg |
IP: ? |
|
Sp.Gr: 1.44 |
Fl.P: ? |
UEL: ? |
LEL: ? |
|
Incompatibilities & Reactivities Chemically-active metals (e.g., potassium, sodium, magnesium, zinc) |
Measurement Methods OSHA 24, 71 See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Hematuria (blood in the urine), cyanosis, nausea, methemoglobinemia, kidney irritation; [potential occupational carcinogen] | |
Target Organs
Liver, blood, kidneys Cancer Site [in animals: liver, lung & bladder tumors] |
See also: INTRODUCTION See ICSC CARD: 0508 |